Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Wen Ma

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Schizophrenia Research|July 22, 2011
Effects of acute paliperidone palmitate treatment in subjects with schizophrenia recently treated with oral risperidoneJennifer Kern Sliwa, Cynthia A Bossie, Yi-Wen Ma, et al.
Psychiatry (Edgmont (Pa. : Township))|December 31, 2010
A Prospective Study Comparing the Long-term Effectiveness of Injectable Risperidone Long-acting Therapy and Oral Aripiprazole in Patients with SchizophreniaWayne Macfadden, Yi-Wen Ma, J Thomas Haskins, et al.
Annals of General Psychiatry|April 13, 2011
Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trialLarry Alphs, Cynthia A Bossie, Jennifer K Sliwa, et al.
International Clinical Psychopharmacology|October 12, 2013
Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparisonDong-Jing Fu, Cynthia A Bossie, Jennifer K Sliwa, et al.
Therapeutic Advances in Psychopharmacology|August 29, 2013
Tolerability of initiation doses of once-monthly paliperidone palmitate in patients with recently diagnosed schizophrenia in an acute treatment trialCynthia A Bossie, Dong-Jing Fu, Jennifer Kern Sliwa, et al.
Clinical Schizophrenia & Related Psychoses|March 1, 2013
Paliperidone palmitate versus risperidone long-acting injection in markedly-to-severely ill schizophrenia subjects: onset of efficacy with recommended initiation regimensDong-Jing Fu, Cynthia A Bossie, Jennifer Kern Sliwa, et al.
BMC Psychiatry|May 17, 2011
Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trialCynthia A Bossie, Jennifer K Sliwa, Yi-Wen Ma, et al.
Expert Opinion on Pharmacotherapy|April 24, 2014
Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophreniaLarry Alphs, Cynthia A Bossie, Dong-Jing Fu, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
Bayesian data analysis in observational comparative effectiveness research: rationale and examplesWilliam H Olson, Concetta Crivera, Yi-Wen Ma, et al.
Neuropsychiatric Disease and Treatment|March 16, 2013
Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychoticsLarry Alphs, Cynthia A Bossie, Jennifer Kern Sliwa, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Schizophrenia Research|July 22, 2011
Effects of acute paliperidone palmitate treatment in subjects with schizophrenia recently treated with oral risperidoneJennifer Kern Sliwa, Cynthia A Bossie, Yi-Wen Ma, et al.
Psychiatry (Edgmont (Pa. : Township))|December 31, 2010
A Prospective Study Comparing the Long-term Effectiveness of Injectable Risperidone Long-acting Therapy and Oral Aripiprazole in Patients with SchizophreniaWayne Macfadden, Yi-Wen Ma, J Thomas Haskins, et al.
Annals of General Psychiatry|April 13, 2011
Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trialLarry Alphs, Cynthia A Bossie, Jennifer K Sliwa, et al.
International Clinical Psychopharmacology|October 12, 2013
Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparisonDong-Jing Fu, Cynthia A Bossie, Jennifer K Sliwa, et al.
Therapeutic Advances in Psychopharmacology|August 29, 2013
Tolerability of initiation doses of once-monthly paliperidone palmitate in patients with recently diagnosed schizophrenia in an acute treatment trialCynthia A Bossie, Dong-Jing Fu, Jennifer Kern Sliwa, et al.
Clinical Schizophrenia & Related Psychoses|March 1, 2013
Paliperidone palmitate versus risperidone long-acting injection in markedly-to-severely ill schizophrenia subjects: onset of efficacy with recommended initiation regimensDong-Jing Fu, Cynthia A Bossie, Jennifer Kern Sliwa, et al.
BMC Psychiatry|May 17, 2011
Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trialCynthia A Bossie, Jennifer K Sliwa, Yi-Wen Ma, et al.
Expert Opinion on Pharmacotherapy|April 24, 2014
Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophreniaLarry Alphs, Cynthia A Bossie, Dong-Jing Fu, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
Bayesian data analysis in observational comparative effectiveness research: rationale and examplesWilliam H Olson, Concetta Crivera, Yi-Wen Ma, et al.
Neuropsychiatric Disease and Treatment|March 16, 2013
Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychoticsLarry Alphs, Cynthia A Bossie, Jennifer Kern Sliwa, et al.
Pageof 2